|
HCV Clinical Trial Research Funding |
| Grants |
Project Number |
Name |
Cost |
Project Title |
|
NCRR |
5M01RR008084-15 |
BALISTRERI, WILLIAM |
$5,201
|
CLINICAL
TRIAL: PEGYLATED INTERFERON +/- RIBAVIRIN FOR CHILDREN WITH
HCV |
| |
5M01RR006192-15 |
BONKOVSKY,
HERBERT |
$4,635
|
CLINICAL
TRIAL: HALT-C TRIAL |
| |
5M01RR000827-33 |
MORGAN,
TIMOTHY |
$66,677
|
CLINICAL
TRIAL: HALT-C |
| |
5M01RR000082-46 |
GREENBERG, HARRY |
$37,396
|
CLINICAL
TRIAL: PEGYLATED INTERFERON RIBAVIRIN FOR CHILDREN WITH HCV
PEDS-C |
| |
5M01RR000065-46 |
ROSEN,
HUGO |
$213,512
|
CLINICAL
TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS
(HALT-C) |
| |
2M01RR001066-31 |
DOUDNA,
JENNIFER |
$4,209
|
CLINICAL
TRIAL: THE HEPATITIS C ANTIVIRAL LONG-TERM TREATMENT AGAINST
CIRRHOSIS |
|
NIDCR |
5M01RR006192-15 |
BONKOVSKY,
HERBERT |
$73
|
CLINICAL
TRIAL: HALT-C TRIAL |
|
|
|
Total |
$331,703
|
|
|
HCV Research Funding for Chronic Liver
Disease Clinical Trials |
| Grants |
Project Number |
Name |
Cost |
Project Title |
|
NCCAM |
5U01AT003573-03 |
RAY,
RATNA |
$255,596
|
A phase
I/II trial of silymarin for chronic liver diseases |
|
|
5U01AT003571-03 |
AFDHAL,
NEZAM |
$275,862
|
Clinical
Center for Phase I/II trials of Silymarin in Chronic Liver
Disease |
|
|
5U01AT003566-03 |
BELLE,
STEVEN |
$393,253
|
Phase
I/II Trials of Silymarin for Chronic Liver Diseases Data
Coordinating Cente |
|
|
5U01AT003560-03 |
FRIEDMAN,
SAMUEL |
$273,536
|
A phase
I/II randomized, placebo controlled trial of silymarin for
hepatitis C |
|
NCRR |
5M01RR001032-33 |
AFDHAL,
NEZAM |
$4,925
|
CLINICAL
TRIAL: PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR
FATTY LIVER |
|
|
2M01RR000046-48 |
HEATON,
ROBERT |
$20,125
|
CLINICAL
TRIAL: SILYMARIN (LEGALON?) IN NON-CIRRHOTIC SUBJECTS WITH
CHRONIC HEP |
|
NIDDK |
5U01AT003573-03 |
RAY,
RATNA |
$76,416
|
A phase
I/II trial of silymarin for chronic liver diseases |
|
|
5U01AT003571-03 |
AFDHAL,
NEZAM |
$82,500
|
Clinical
Center for Phase I/II trials of Silymarin in Chronic Liver
Disease |
|
|
5U01AT003566-03 |
BELLE,
STEVEN |
$169,852
|
Phase
I/II Trials of Silymarin for Chronic Liver Diseases Data
Coordinating Cente |
|
|
5U01AT003560-03 |
FRIEDMAN,
SAMUEL |
$71,088
|
A phase
I/II randomized, placebo controlled trial of silymarin for
hepatitis C |
|
|
|
Total |
$1,623,153
|
|
Source: National Institutes of Health Research Portfolio
Online Reporting Tool (RePORT) Reports,
Data and Analyses of NIH Research Activities
Retrieved on March 18, 2009
http://report.nih.gov/rcdc/categories/ProjectSearch.aspx?FY=2008&DCat=Hepatitis+-+C
Permission is granted to use all information from this website
in pursuit of ending NIH's "Trans-Plan" discriminatory practices against HCV
research funding allocations.
Please Credit: HCVets.com Educational Website &
Support Forums for Military Related HCV Exposures.
Contact HepCop
Email:
Staff
|
